200,000+ products from a single source!
sales@angenechem.com
CAS No: 521064-34-6 Catalog No: AG01FILK MDL No:
Title | Journal |
---|---|
Antileukemic activity of lysophosphatidic acid acyltransferase-beta inhibitor CT32228 in chronic myelogenous leukemia sensitive and resistant to imatinib. | Clinical cancer research : an official journal of the American Association for Cancer Research 20061101 |
Effect of lysophosphatidic acid acyltransferase-beta inhibition in acute leukemia. | Leukemia research 20060801 |
Lysophosphatidic acid acyltransferase-beta is a prognostic marker and therapeutic target in gynecologic malignancies. | Cancer research 20051015 |
Induction of apoptosis using inhibitors of lysophosphatidic acid acyltransferase-beta and anti-CD20 monoclonal antibodies for treatment of human non-Hodgkin's lymphomas. | Clinical cancer research : an official journal of the American Association for Cancer Research 20050701 |
Synthesis and SAR of 2-arylbenzoxazoles, benzothiazoles and benzimidazoles as inhibitors of lysophosphatidic acid acyltransferase-beta. | Bioorganic & medicinal chemistry letters 20040322 |
© 2019 Angene International Limited. All rights Reserved.